These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 7670712)

  • 1. [Hormonal problems in diseases of the breast].
    Strnad P; Vachousek J; Cech E; Smejkal V; Velek J
    Ceska Gynekol; 1995 Jun; 60(3):164-6. PubMed ID: 7670712
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hormonal contraceptives and their relationship to breast cancer].
    Habánová M; Svikruhová J; Sláviková E
    Klin Onkol; 2010; 23(6):428-32. PubMed ID: 21351420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Re: Breast cancer risk in relation to the interval between menopause and starting hormone therapy.
    Grant EC
    J Natl Cancer Inst; 2011 Jul; 103(13):1069; reply 1069-70. PubMed ID: 21700925
    [No Abstract]   [Full Text] [Related]  

  • 4. [The taking of sex hormone preparations and the risk of developing breast cancer].
    Levshin VF
    Vopr Onkol; 1992; 38(8):899-909. PubMed ID: 1300798
    [No Abstract]   [Full Text] [Related]  

  • 5. Epidemiologic aspects of exogenous progestagens in relation to their role in pathogenesis of human breast cancer.
    van Leeuwen FE
    Acta Endocrinol (Copenh); 1991; 125 Suppl 1():13-26. PubMed ID: 1801500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of hormone-replacement therapy and steroid contraceptives in menopause as an oncological and epidemiological problem: is it a risk and/or benefit?].
    Bershteĭn LM
    Vopr Onkol; 2005; 51(6):636-46. PubMed ID: 17037027
    [No Abstract]   [Full Text] [Related]  

  • 7. [The role of sex steroids for genesis of breast and endometrial cancer].
    Distler W
    Gynakologe; 1993 Apr; 26(2):94-9. PubMed ID: 8508990
    [No Abstract]   [Full Text] [Related]  

  • 8. Breast cancer and hormone exposure.
    Grant EC; Antony HM; Myhill S; Price EH; Steel CM
    Lancet; 1996 Sep; 348(9028):682; author reply 683. PubMed ID: 8782768
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hormonal therapy in systemic lupus erythematosus].
    Kaliterna DM; Krstulović DM; Radić M
    Reumatizam; 2009; 56(2):41-3. PubMed ID: 20429261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Do sex steroids cause breast and genital cancers? Epidemiologic data--the current status (July 1993)].
    Beller FK
    Geburtshilfe Frauenheilkd; 1993 Oct; 53(10):657-66. PubMed ID: 8270146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex steroids and breast cancer prevention.
    Spicer DV; Pike MC
    J Natl Cancer Inst Monogr; 1994; (16):139-47. PubMed ID: 7999456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [How hazardous is the use of female steroid hormones?].
    Orbo A; Sager G
    Tidsskr Nor Laegeforen; 1997 Mar; 117(7):972-6. PubMed ID: 9103012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormonal exposures and breast cancer in a sample of women with systemic lupus erythematosus.
    Bernatsky S; Clarke A; Ramsey-Goldman R; Joseph L; Boivin JF; Rajan R; Moore AD; Leung MH; Allen A; Gordon C
    Rheumatology (Oxford); 2004 Sep; 43(9):1178-81. PubMed ID: 15226516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hormonal contraception and postmenopausal estrogen substitution in relation to malignant tumors].
    Lauritzen C
    Zentralbl Gynakol; 1990; 112(17):1071-90. PubMed ID: 2264417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormone replacement therapy and risk of breast cancer.
    Grant EC
    JAMA; 2002 May; 287(18):2360; author reply 2361. PubMed ID: 11988049
    [No Abstract]   [Full Text] [Related]  

  • 16. [Breast carcinoma; advice concerning after care, hormonal contraception or substitution with estrogens, and pregnancy].
    Nortier JW; Kluck HM; Sybrandy R; Beex LV
    Ned Tijdschr Geneeskd; 1990 Oct; 134(40):1934-7. PubMed ID: 2172843
    [No Abstract]   [Full Text] [Related]  

  • 17. Estrogens and breast cancer.
    Feigelson HS; Henderson BE
    Carcinogenesis; 1996 Nov; 17(11):2279-84. PubMed ID: 8968038
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hormonal replacement therapy and oral contraception. Risk of induction or reactivation of gynecologic malignancies].
    Kimmig R; Seehaus D; Scheidel P; Hepp H
    Gynakol Geburtshilfliche Rundsch; 1995; 35(2):72-8. PubMed ID: 7620385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Oral contraceptives and breast cancer].
    Haga S; Kinoshita J
    Nihon Rinsho; 2000 Apr; 58 Suppl():563-5. PubMed ID: 11026050
    [No Abstract]   [Full Text] [Related]  

  • 20. Oestrogen and breast cancer.
    Snyder RD
    Med J Aust; 1992 Dec 7-21; 157(11-12):838-40. PubMed ID: 1454026
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.